All News about Travere Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20230717969028/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Travere Therapeutics
June 07, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: Travere Therapeutics Q1 Earnings
May 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Travere Therapeutics
May 03, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Travere Therapeutics
April 17, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://www.investors.com/wp-content/uploads/2019/10/stock-drugs-needle-01-adobe.jpg)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://investorplace.com/wp-content/uploads/2022/04/pte_biotech_1600-1024x576.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/02/3628710.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230502005775/en/827144/22/Schall-Firm-Logo-640x360.jpg)
![](https://www.investors.com/wp-content/uploads/2017/11/Stock-drugBottlePills-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/02/tvtx.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://mms.businesswire.com/media/20230501005777/en/827144/22/Schall-Firm-Logo-640x360.jpg)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/04/03/tvtx.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.